Article
Molecular approaches to developmental malformations using analogous forms of valproic acid.
Congenital anomalies - 1 Jun 2006
Okada Akinobu, Fujiwara Michio
Abstract excerpt
The teratogenic potential of valproic acid has been well established both in experimental models and in human clinical studies. Evidence from many previous studies has shown that VPA is an appropriate drug model for studying chemical structure-teratogenicity relationships. Using molecular techniques of DNA microarray (GeneChip system) or quantitative real-time polymerase chain reaction with low teratogenic VPA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
